aafq smgt-glp-1 New Eli Lilly trial suggests weight loss pill is as strong as Ozempic Swissmedic issues warning against falsified

Stroke in the 21st century: a snapshot of the burden, epidemiology, and quality of life

Q: Why is it not approved for medical use

HIV lipodystrophy patients showed about 15.2% visceral fat reduction at 26 weeks versus placebo, plus favorable lipid and trunk-fat changes

How can L-Carnitine help with weight loss

Graphical Abstract 1 Introduction Neurological conditions, including central nervous system (CNS) disorders, have emerged as the leading cause of illness and disability worldwide, affecting more than 3 billion individuals more than one-third of the global population based on a study in 2021 (GBD, 2021 Nervous System Disorders Collaborators, 2024)